Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/24 17:45 | 4/15/24 | CRSP | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | 6 | M.dm | 4,488 | 36.85 | 0 | 122 | 43 | 408 | D | ||||||||||||||
4/17/24 17:45 | 4/15/24 | CRSP | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | 6 | S.dm | -4,488 | 36.85 | 0 | -122 | 408 | D | |||||||||||||||
3/18/24 17:45 | 3/14/24 | CRSP | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | 2 | M.d | 256 | 18.94 | 0 | 14 | 6 | D | |||||||||||||||
3/18/24 17:45 | 3/15/24 | CRSP | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | 2 | S.d | -256 | 18.94 | 0 | -14 | 6 | D | |||||||||||||||
3/12/24 17:45 | 3/10/24 | CRSP | Health | BioPrd | Biological Products, (No Diag | Kasinger James R. | MA | O | GC,Secre | 2 | M.dm | 305 | 26.03 | 0 | 12 | 24 | 61 | D | ||||||||||||||
3/12/24 17:45 | 3/11/24 | CRSP | Health | BioPrd | Biological Products, (No Diag | Kasinger James R. | MA | O | GC,Secre | 2 | S.dm | -305 | 26.03 | 0 | -12 | 61 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |